# Datavant

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/datavant

- Industry: Software
- Headquarters: Phoenix, US
- Website: www.datavant.com
- Total disclosed funding: $40M
- Latest round: Series B (Oct 8, 2020)
- Investors on record: 5

## About

Datavant specializes in health data management, offering innovative solutions for secure data exchange and interoperability across healthcare systems. The company emphasizes actionable insights through its comprehensive data platform. Founded in 2017 in San Francisco, US, Datavant provides a health data platform enabling secure data connections for healthcare organizations. In September 2026, Neuberger Berman, along with KKR and New Mountain Capital agreed to acquire a minority stake in Datavant, Inc. The deal subject to customary closing conditions and is expected to be completed in the fourth quarter of 2026. The firm was founded by Travis May, Datavant has experienced growth from its inception, focusing on expanding its data services in the healthcare sector. As of September 2026, the company is led by its CEO- Kyle Armbrester. Datavant has experienced growth from its inception, focusing on expanding its data services in the healthcare sector.Datavant offers a robust health data platform that emphasizes secure, accessible, and actionable health data management. Its core product suite, Datavant Connect, provides tokenization and data linkage solutions that allow healthcare organizations to connect and enrich patient data while ensuring compliance with privacy regulations. The platform facilitates the exchange of over 60 million healthcare records across a network of more than 70,000 hospitals and clinics, including 75% of the largest health systems, and connects with over 300 real-world data partners. Datavant serves a diverse range of clients, including health plans, life sciences companies, healthcare providers, and researchers, focusing on applications such as risk adjustment coding, clinical trial management, and data analytics, with its solutions primarily deployed across the United States.Datavant generates revenue primarily through partnerships and subscription models tailored to various customer segments within the healthcare ecosystem. Transactions typically involve health plans and providers accessing Datavant’s platform for data connectivity and analytics services. These arrangements include service agreements that facilitate the use of Datavant's data retrieval and linkage capabilities on a subscription basis, allowing clients to pay for access to specific features and functionalities that meet their operational needs, thus ensuring a continuous flow of revenue as organizations engage with Datavant's solutions.  The company is focusing on expanding its product offerings, specifically enhancing its data integration capabilities and launching new tools designed for improved health data analytics. Datavant plans to penetrate additional markets, with specific efforts aimed at increasing its presence in international regions, leveraging recent funding to support these expansion efforts.

## Funding rounds

- Series B, Oct 8, 2020, $40M — Johnson & Johnson Innovation, Transformation Capital, Roivant Sciences Ltd., Cigna Ventures, Flex Capital

## Investors

- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series B
- Transformation Capital (https://capitalatlas.ai/funds/transformation-capital) — Series B
- Roivant Sciences Ltd. — Series B
- Cigna Ventures (https://capitalatlas.ai/funds/cigna-ventures) — Series B
- Flex Capital — Series B